参考文献:
[1]Zhao Y,Guo L,Li J,et al.Molecular epidemiology,antimicrobial susceptibility,and pulsed-field gel electrophoresis genotyping of Pseudomonas aeruginosa isolates from mink[J].Canadian Journal of Veterinary Research,2018,82(4):256-263.
[2]Fito-Boncompte L,Chapalain A,Bouffartigues E,et al.Full virulence of Pseudomonas aeruginosa requires OprF[J].Infection Immunity,2011,79(3):1176-1186.
[3]Ding B,von Specht B U,Li Y.OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa[J].Vaccine,2010,28(25):4119-4122.
[4]Finke M,Duchêne M,Eckhardt A,et al.Protection against experimental Pseudomonas aeruginosa infection by recombinant P.aeruginosa lipoprotein I expressed in Escherichia coli[J].Infection Immunity,1990,58(7):2241-2244.
[5]Zhang M,Sun C,Gu J,et al.Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa[J].Microbiology and Immunology,2015,59(9):533-544.
[6]Hughes E E,Gilleland H Jr.Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P.aeruginosa infection in a murine acute pneumonia model[J].Vaccine,1995,13(18):1750-1753.
[7]Bodey G P,Bolivar R,Fainstein V,et al.Infections caused by Pseudomonas aeruginosa[J].Reviews of Infectious Diseases,1983,5(6):279-313.
[8]Hilleman M R.Vaccines in historic evolution and perspective: A narrative of vaccine discoveries[J].Vaccine,2000,18(15):1436-1447.
[9]蒋增海,邓同炜,徐耀辉,等.猪源绿脓杆菌的分离鉴定及16S rRNA基因同源性分析[J].河南农业科学,2017,46(4):118-120,133.
[10]Sharma A,Krause A,Worgall S.Recent developments for Pseudomonas vaccines[J].Human Vaccines,2011,7(10):999-1011.
[11]Lesouhaitier O,Veron W,Chapalain A,et al.Gram-negative bacterial sensors for eukaryotic signal molecules[J].Sensors (Basel),2009,9(9):6967-6990.
[12]Nestorovich- E M,Sugawara E,Nikaido H,et al.Pseudomonas aeruginosa porin OprF: Properties of the channel[J].The Journal of Biological Chemistry,2006,281(24):16230-16237.
[13]Horzempa J,Dean C R,Goldberg J B,et al.Pseudomonas aeruginosa 1244 pilin glycosylation: Glycan substrate recognition[J].Journal of Bacteriology,2006,188(12):4244-4252.
[14]Azghani A O,Idell S,Bains M,et al.Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture[J].Microbial Pathogenesis,2002,33(3):109-114.
[15]Yoon S S,Hennigan R F,Hilliard G M,et al.Pseudomonas aeruginosa anaerobic respiration in biofilms:Relationships to cystic fibrosis pathogenesis[J].Developmental Cell,2002,3(4):593-603.
[16]Wu L C,Estrada O,Zaborina O,et al.Recognition of host immune activation by Pseudomonas aeruginosa[J].Science,2005,309(6):774-777.
[17]Wagner V E,Frelinger J G,Barth R K,et al.Quorum sensing:Dynamic response of Pseudomonas aeruginosa to external signals[J].Trends Microbiology,2006,14(2):55-58.
[18]Alayande A B,Aung M M,Kim I S.Correlation between quorum sensing signal molecules and Pseudomonas aeruginosa’s biofilm development and virulency[J].Current Microbiology,2018,75(7):787-793.
[19]Sugawara E,Nagano K,Nikaido H.Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa[J].Febs Journal,2012,279(6):910-918.
[20]Wu L,Estrada O,Zaborina O,et al.Recognition of host immune activation by Pseudomonas aeruginosa[J].Science,2005,309:774-777.
[21]Bouffartigues E,Moscoso J A,Duchesne R,et al.The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level[J].Frontiers Microbiology,2015,6:630-673.
[22]Loots K,Revets H,Goddeeris B M.Attachment of the outer membrane lipoprotein(OprI) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens[J].Vaccine,2008,26(4):546-551.
[23]Kazemi E,Owlia P,Jahangiri A,et al.Conserved OprF as a selective immunogen against Pseudomonas aeruginosa[J].Iran Journal of Pathology,2017,58(2):165-170.
[24]Knapp B,Hundt E,Lenz U,et al.A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa[J].Vaccine,1999,17(13/14):1663-1666.
[25]Mansouri E,Blome-eberwein S,Gabelsberger J,et al.Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients[J].FEMS Immunology and Medical Microbiology,2003,37(2/3):161-166.
|